Vinaikra has the possibility of causing liver function damage, the use of drugs need to pay attention to monitoring transaminases and other indicators, and pay attention to adverse reactions and contraindications. Vinaikra is mainly used for the treatment of chronic lymphocytic leukemia, set cell lymphoma and other lymphohematopoietic malignancies. During the use of the drug, manifestations of hepatic impairment such as elevated transaminases and abnormal bilirubin levels may occur. The drug is disposed of by the liver and mostly eliminated through feces, so it is important to monitor liver function levels regularly during treatment. In addition, in the event of severe hemopenia, infection, etc. during use, prompt disposal or suspension of the drug is required. The drug is contraindicated in pregnancy. The drug needs to be administered by an experienced physician and unauthorized use of the drug is prohibited. Chewing or crushing of the drug is prohibited when taking the drug orally; the drug is prohibited during pregnancy. Either initiation of medication or adjustment of the medication regimen or discontinuation of the medication requires a full assessment by a clinician; unauthorized use of the medication or adjustment of the medication regimen is prohibited.